beta-alanine has been researched along with Coagulation Disorders, Blood in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dabigatran is a direct thrombin inhibitor indicated for stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation." | 3.80 | [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. ( Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachellerie, B | 1 |
| Ruiz, S | 1 |
| Conil, JM | 1 |
| Crognier, L | 1 |
| Seguin, T | 1 |
| Georges, B | 1 |
| Fourcade, O | 1 |
| Mousa, SA | 1 |
| Asakura, H | 1 |
| Alpert, JS | 1 |
| Khoo, TL | 1 |
| Weatherburn, C | 1 |
| Kershaw, G | 1 |
| Reddel, CJ | 1 |
| Curnow, J | 1 |
| Dunkley, S | 1 |
| Huang, GS | 1 |
| Chance, EA | 1 |
| Gastineau, DA | 1 |
| Gertz, MA | 1 |
| Daniels, TM | 1 |
| Kyle, RA | 1 |
| Bowie, EJ | 1 |
1 review available for beta-alanine and Coagulation Disorders, Blood
| Article | Year |
|---|---|
[Interpretation of hemostatic and fibrinolytic markers].
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation Disorders; Blood Coagula | 2011 |
6 other studies available for beta-alanine and Coagulation Disorders, Blood
| Article | Year |
|---|---|
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzi | 2014 |
The future of anticoagulant therapy.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Drug Approval | 2012 |
New directions in anticoagulation.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Clinical Trials as Topic; | 2012 |
The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Disorders; Blood C | 2013 |
When dabigatran and trauma collide.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigat | 2013 |
Inhibitor of the thrombin time in systemic amyloidosis: a common coagulation abnormality.
Topics: Amyloidosis; beta-Alanine; Blood Coagulation Disorders; Fibrinogen; Heart Failure; Humans; Nephrotic | 1991 |